Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Ingredient Supply Trends Can Shed Light On Adulteration

This article was originally published in The Tan Sheet

Executive Summary

The sudden abundance of formerly scarce raw ingredients for dietary supplements may signal economically motivated adulteration

You may also be interested in...



Ingredient Safety Concerns Rise Among FDA Enforcement Priorities

Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.

Ingredient Safety Concerns Rise Among FDA Enforcement Priorities

Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.

GAO Adulteration Report Points To Disconnect Among FDA Offices

Food and drug attorneys critique the Government Accountability Office’s report on FDA’s efforts to counter economically motivated adulteration, which calls for greater cross-agency collaboration.

Related Content

Topics

UsernamePublicRestriction

Register

PS102904

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel